HomeStocksNATCOPHARM

N

Natco Pharma

NATCOPHARM Share Price

Healthcare
mtf MTF 2.94x

1,011.60

34.70 (3.55%)profit

as on 15 Jul 2025 at 15:54

1D
img
192
img
33.33% Buy
Bulb

Today Natco Pharma opened at 982.15 while its previous close was at 976.90. In todays trading session NATCOPHARM reached a high of 1,018.00 and low of 970.15. The average traded price for today is 999.67. The 50 DMA stands at 888.79 and 200 DMA is at 1,101.97. Looking at intraday trend, the stock is in Uptrend.

chartsarrowTradingViewarrow
TradingView Logo

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

NATCOPHARM Stock Performance

Markets Today

High

1,018.00

Low

970.15

Open at

982.15

Prev Close

976.90

Volumes

15,66,701

Avg Price

999.67

Lower Circuit

809.30

Upper Circuit

1,213.90

Last Traded Details

Quantity

100

Time

15:54:08

Price Movement

970.15
1,011.60
1,018.00
Loss 4.27%down side
up side0.63% profit

Historical Performance

3 M High

1,027.00

3 M Low

775.00

1 Yr High

1,639.00

1 Yr Low

726.80

3 Yr High

1,639.00

3 Yr Low

502.00

5 Yr High

1,639.00

5 Yr Low

502.00

1-Year Performance

726.80
1,011.60
1,639.00
loss4.27%down side
up side0.63% profit

NATCOPHARM Analyst Rating

Buy

Analysts have suggested that investors can Buy this Stock

- By Refinitiv from 6 analysts

Buy

33.33%

Hold

33.33%

Sell

33.33%


NATCOPHARM Latest News

View All News arrow
news

No news for this stock at the moment.


NATCOPHARM Share Price History

View Price History arrow

Close Price

Volume

NATCOPHARM share price in last 10 trading sessions

DayOpenCloseChange%Day HighDay LowVolume
15 Jul 2025982.151,011.60
3.00% profit
1,018.00970.1515,66,701
14 Jul 2025962.90976.90
1.45% profit
984.00955.108,76,625
11 Jul 2025991.10961.80
-2.96% Loss
997.05960.1013,55,112
10 Jul 20251,020.95998.30
-2.22% Loss
1,022.80996.608,36,069
09 Jul 2025977.501,017.75
4.12% profit
1,027.00972.3526,38,041
08 Jul 2025975.50984.95
0.97% profit
988.60960.1012,56,338
07 Jul 20251,002.00973.60
-2.83% Loss
1,006.00970.3015,19,115
04 Jul 2025976.20998.60
2.29% profit
1,002.90965.7025,69,046
03 Jul 2025928.00973.60
4.91% profit
977.00917.0559,26,568
02 Jul 2025940.00921.95
-1.92% Loss
940.95917.558,06,341

NATCOPHARM Fundamentals

View Fundamentals arrow

Company Valuation

Market Cap (₹ Cr.)

18,119

PE Ratio

9.30

PB Ratio

2.30

Dividend Yield

0.61%

ROE

23.72%

ROCE

28.53%

Book Value (₹)

424.71

Face Value (₹)

2.00


Share Holding Pattern

Held ByMar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Promoters
49.71%49.71%49.62%49.62%49.56%
Domestic Institutional Investors (DII)
9.70%7.87%6.75%5.57%5.65%
Foreign Institutional Investors (FII)
16.14%17.45%17.51%17.94%17.49%
Public Investors
20.60%21.59%22.60%23.34%23.68%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government


NATCOPHARM Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

SIP Logo

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.


NATCOPHARM Technicals

View Technicals arrow

Moving Averages

PeriodSimpleSignal
5-SMA987.94Bearish
10-SMA974.05Bullish
20-SMA927.39Bullish
50-SMA888.79Bullish
100-SMA854.43Bullish
200-SMA1,101.97Bearish

Technical Indicators

IndicatorValueAction
RSI(14)59.55Neutral
ATR(14)31.67Less Volatile
STOCH(9,6)71.66Neutral
STOCH RSI(14)49.90Neutral
MACD(12,26)4.42Bullish
ADX(14)34.00Strong Trend

Summary of Technical Indicators for NATCOPHARM


NATCOPHARM Financials Summary
View By:
Revenue
EBITDA
Net Profit
EPS
Revenue

In Crores

Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
1,1101,4111,4356511,287

NATCOPHARM Financials

View By:

Income Statement

In Crores

Quarterly StatementMar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Revenue1,1101,4111,4356511,287
Expenses571558567436673
Operating Profit49780580439548
Operating Profit Margin %47%59%59%8%45%
Other Income42486417666
EBITDA539853868215614
Interest654410
Depreciation5644464798
Profit Before Tax478804818164506
Tax %19%17%17%19%20%
Net Profit386669677132406
EPS223738723

Balance Sheet

In Crores

Yearly Balance SheetMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Share Capital3737373636
Reserve & Surplus4,0854,2274,8375,8177,571
Minority Interest20005
Non Current Liabilities1431351018075
Current Liabilities526710683973944
Total Liabilities4,7925,1095,6576,9068,631
Fixed Assets2,0232,3122,4272,4912,866
Capital Work in Progress22313064137225
Investments304308392539766
Other Assets2,2422,3602,7743,7390
Total Assets4,7925,1095,6576,9068,631

Cash Flow

In Crores

Yearly Cash FlowMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Operating Activities417299478491,212
Investing Activities-175-1074-465-1,026
Financing Activities-251-18635-363-247
Net Cash Flow-968521-62

Past Corporate Actions

DateCorporate ActionInformation
12 May 2025
QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025
DIVIDEND Dividend
₹ 1.50 /share
30 Jan 2025
QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024
DIVIDEND Dividend
₹ 1.50 /share
28 Oct 2024
QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA

ScanX Logo

Get In-depth View of NATCOPHARM Quaterly Results, Balance Sheet, Cashflows & Corporate Action.

Use Screener

NATCOPHARM Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2023-244,095
51.8% profit
1,819
105.09% profit
FY 2022-233,674
32.99% profit
1,307
358.02% profit
FY 2021-222,437
6.91% profit
637
-55.06% Loss




Open IPOs

View All arrow
No Data

There are no Open IPOs at the moment.



What’s New In The Market
news

At this moment, No news for this stock


FAQs

Natco Pharma share price as of today is ₹ 1,011.60 as on 15 Jul 2025 at 15:54.
The 52W high of Natco Pharma is ₹ 1,639.00 and 52W low is ₹ 726.80 as of 15 Jul 2025 at 15:54.
The past returns of Natco Pharma share are -
  • Past 1 year: -16.27%
  • Past 3 years: 58.86%
  • Past 5 years: 51.71%
The PE and PB ratio of Natco Pharma stands at 9.30 and 2.30 respectively as on 15 Jul 2025 at 15:54.
The EPS of Natco Pharma is 22.70 for the quarter ended Mar 2025 and 105.26 for the financial year 2024-25.
The shareholding pattern of Natco Pharma is as follows:
  • DIIs - 5.65%
  • FII - 17.49%
  • Promoters - 49.56%
  • Public Investors 23.68%
  • Goverenment - 0.00%
Yes, you can buy shares of Natco Pharma online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Natco Pharma stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Natco Pharma share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Natco Pharma.
You can easily buy the shares of Natco Pharma even after the markets are closed using the After Market Order feature on Dhan Trading App.
Candle bars with Screen
Invest in NATCOPHARM
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2025 Moneylicious Securities Private Limited. All rights reserved. CIN: U74999MH2012PTC433549 Moneylicious Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Moneylicious Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Moneylicious Securities Private Limited. All DHAN clients are registered under Moneylicious Securities Private Limited. Clients are advised to refer to our company as Moneylicious Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / Moneylicious / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Moneylicious Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors